IL28B C/C GENOTYPE IS PREDICTIVE OF >= 1 LOG10 IU/ML REDUCTION IN PLASMA HCV RNA AFTER 4 WEEKS OF PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV) THERAPY: IMPLICATIONS FOR THE USE OF THE LEAD-IN STRATEGY FOR DIRECT-ACTING ANTIVIRAL-BASED TREATMENT REGIMENS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Thompson, AJ; Clark, PJ; Tillmann, HL; Patel, K; Naggie, S; Poordad, FF; Lawitz, E; Bacon, BR; Vierling, JM; Noviello, S; Brass, CA; Albrecht, JK; Goldstein, DB; McHutchison, JG; Sulkowski, MS; Muir, AJ

Published Date

  • October 1, 2011

Published In

Volume / Issue

  • 54 /

Start / End Page

  • 436A - 437A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Conference Location

  • San Francisco, CA

Conference Start Date

  • November 4, 2011

Conference End Date

  • November 8, 2011